🚀 We're expanding fast at Signatur Biosciences! We're hiring for 3 new positions to join us as we're setting up our new lab! 🧬 We are seeking exceptional profiles to join our team. If you have a strong background in lab work and building diagnostics — and you share our passion for making precision testing accessible globally, we'd love to hear from you. ➡️ For more details on the role and how to apply, check out our full job description linked here: 🥼 Scientist: https://lnkd.in/eNr3gVZA 👩🔬 Associate Scientist: https://lnkd.in/eWnecWbP 🧪 Senior Technical Assistant: https://lnkd.in/eEdGN8g6 Let’s transform healthcare together! Please share this opportunity with anyone in your network who might be the perfect fit. 🌍 #WeAreHiring #hiring #Scientist #AssociateScientist #SeniorTechnicalAssistant #LabManagement #PrecisionDiagnostics #HealthcareInnovation #SignaturBiosciences
Signatur Biosciences
Biotechnology Research
London, UK 1,228 followers
Making precision diagnostics accessible.
About us
Signatur Biosciences makes precision diagnostics more accessible, starting by bringing breast cancer testing within reach for women around the world. Traditional tests used to guide therapy are slow and expensive due to their reliance on complex, centralized facilities. Our tests are designed to seamlessly integrate with standard instruments and workflows already in place in every clinical lab. Our assays empower local labs to deliver results in hours instead of weeks and at a fraction of the cost, significantly increasing accessibility, including for underserved patient populations. Signatur Biosciences is a spinout backed by YCombinator, founded by bioengineers from Imperial College and Oxford University.
- Website
-
https://www.signatur.bio/
External link for Signatur Biosciences
- Industry
- Biotechnology Research
- Company size
- 2-10 employees
- Headquarters
- London, UK
- Type
- Privately Held
- Founded
- 2022
Locations
-
Primary
London, UK, GB
Employees at Signatur Biosciences
-
Adrian Moody
Experienced leader of IVD Product Development teams with a track record of delivering 510(k), PMA and CE-IVD products to market
-
Celestin de Wergifosse
Co-founder and CEO at Signatur Biosciences (YC S22)
-
Francesca Smith, PhD
Lead Scientist @ Signatur Biosciences | PhD in Materials Science | Bioengineering | Biophysics | Nucleic Acid Nanotechnology
-
Nahimi Amare Bekele
RA/QA Lead | IVD | Europe | US
Updates
-
🎉 We’re so excited to share that we have been awarded phase 1 out of a £900K two-phase SBRI Healthcare Grant Competition for Women’s Health! 🌟 This grant supports startups accelerating innovation in Women’s Health across the UK. This perfectly aligns with our mission to empower women around the world by making precision diagnostics more accessible. Our focus is to enable women to make informed treatment decisions about their breast cancer care, helping them avoid unnecessary chemotherapy. ➡️ SBRI Healthcare is an Accelerated Access Collaborative initiative, NHS Transformation Directorate, supported by the Health Innovation Network. 🙏 This achievement reflects our team's relentless hard work and dedication. #SBRIHealthcare #Innovation #Womenshealth #healthtech #healthcare #NHS #HealthcareInnovation #PrecisionDiagnostics #SignaturBiosciences #SBRI #moleculardiagnostics
-
🎉 We are super excited to announce that we have been awarded the 2024 UK Research and Innovation Department STFC grant, supporting 28 game-changing startups. 🌟 This prestigious grant supports top startups accelerating innovation across the UK, and we are proud to be 1 of 5 selected within the biotechnology and biological sciences category. This grant will propel our efforts in making precision diagnostics more accessible globally. 🙏 It’s a testament to the hard work and dedication of our incredible team. Read more about how STFC is backing us and other innovative startups below #BioBIC #STFC #UKInnovation #HealthcareInnovation #PrecisionDiagnostics #SignaturBiosciences #UKRI #moleculardiagnostics
-
🌟 We're hiring at Signatur Biosciences! We're looking for our Head of Lab Operations to join us as we're setting up our new lab! 🧬 We are seeking an exceptional profile to spearhead our lab operations. If you have a strong background in lab management and building diagnostics — and you share our passion for making precision testing accessible globally, we'd love to hear from you. ➡️ For more details on the role and how to apply, check out our full job description linked here: https://lnkd.in/eMGWE7JD Let’s transform healthcare together! Feel free to share this opportunity with anyone in your network who might be the perfect fit. 🌍 #WeAreHiring #hiring #LabManagement #PrecisionDiagnostics #HealthcareInnovation #SignaturBiosciences
-
🌟 We're beyond excited to share that Signatur Biosciences has now been shortlisted as one of the top 20 startups globally by world-renowned Slush startup competition. Celestin de Wergifosse, our CEO, will be pitching in Helsinki later this month for this final stage. 🚀 This recognition highlights our team’s dedication to making precision diagnostics accessible to all, at a global scale. We are honored to have made it this far. 🌲 If you're at Slush, come by and see what makes our approach to molecular diagnostics so revolutionary. Let’s connect and explore the possibilities together! #Slush20 #StartupLife #PrecisionDiagnostics #HealthcareInnovation #SignaturBiosciences
-
-
🚀 Exciting news from Signatur Biosciences! We're thrilled to share that we've climbed even higher at the global Slush competition, now ranking among the top 50 startups! 🧬 This milestone highlights our team's relentless dedication and innovative spirit in making precision diagnostics accessible. 🙏 A huge thank you to the Slush team for recognizing our efforts and to everyone supporting our mission. We're motivated more than ever to keep pushing the boundaries of what's possible in healthcare. #Slush50 #HealthcareInnovation #StartupLife #PrecisionDiagnostics #SignaturBiosciences #slush
-
-
🌟🚀 Signatur Biosciences has been selected as one of the top 100 startups in the global Slush Competition! This recognition is a testament to our team's hard work and innovation to make precision diagnostics more accessible for everyone, globally. 🙏 Thank you to everyone at Slush for this great opportunity to showcase our platform in such a prestigious competition. We are excited to continue our journey, driving forward the future of healthcare. #Slush100 #Innovation #Startup #PrecisionDiagnostics #SignaturBiosciences
-
-
🔥🎉 We are super excited to announce that Adrian Moody has joined Signatur Biosciences as our new Head of Development. With 25 years of invaluable experience, Adrian is an exceptional addition to our team. Adrian has previously led global development efforts at Qiagen and served as the Head of Development at Biocartis. His extensive background perfectly aligns with our mission at SigBio, and his expertise from these leading companies significantly propels our development activities forward. We are delighted to welcome Adrian aboard and are excited about the depth of knowledge and experience he brings to our team. Here’s to new beginnings and monumental achievements together! #NewHire #TeamGrowth #WelcomeAboard #HealthcareInnovation #SignaturBiosciences
-